MRPL47 deficiency drives mitochondrial dysfunction via ROS-p38-p21 signaling in non-small cell lung cancer
Nikita Bhandari1, Yengkhom Ghanapriya Devi2, Disha Acharya1
1Department of Biosciences and Bioengineering, Indian Institute of Technology Dharwad, Dharwad, India.
Abstract:
Mitoribosomes are pivotal for cellular energy metabolism through the synthesis of proteins essential for the oxidative phosphorylation system. Although mitoribosomal dysregulation has been implicated in cancer, the genomic landscape of mitoribosomal proteins (MRPs) in nonsmall cell lung cancer (NSCLC) remains largely uncharacterized. In this study, we conducted a comprehensive analysis of expression, copy number variations, and mutations of MRPs using data from TCGA-NSCLC patients. This screen identified MRPL47 as a significantly amplified and overexpressed mitoribosomal gene in NSCLC. Validation across three independent datasets (n = 1513) confirmed MRPL47 as a robust and independent prognostic marker for poor survival. Functionally, MRPL47 inhibition significantly reduced NSCLC cell proliferation and migration. Intriguingly, MRPL47 depletion selectively impaired the translation of a subset of mitochondrial proteins, rather than causing a global defect, leading to impaired assembly of electron transport chain Complexes I and III. This resulted in a defective oxidative phosphorylation system, characterized by decreased ATP synthesis and elevated mitochondrial reactive oxygen species (ROS) levels. Transcriptomic analysis revealed a significant downregulation of E2F pathway activity in MRPL47-knockdown cells, with MRPL47 expression correlating with E2F target gene expression at both RNA and protein levels. Mechanistically, MRPL47 knockdown induced ROS accumulation, which promoted p38 phosphorylation and subsequent upregulation of p21. Increased p21, in turn, led to Rb hypophosphorylation, thereby inhibiting E2F activity and inducing G1 cell cycle arrest and senescence. Altogether, these findings establish that MRPL47 is amplified and overexpressed in NSCLC, functions as a strong prognostic predictor, and critically promotes tumor progression by modulating mitochondrial function and the ROS-p38-p21-Rb-E2F signaling axis.
Insights
Amplification of the mitoribosomal gene MRPL47 drives nonsmall cell lung cancer (NSCLC) progression by impairing mitochondrial function and promoting cell cycle arrest. MRPL47 is a prognostic marker for poor survival in NSCLC patients.
Area of Science:
- Mitochondrial Biology
- Cancer Genomics
- Molecular Oncology
Background:
- Mitoribosomes synthesize proteins crucial for cellular energy via oxidative phosphorylation.
- Mitoribosomal dysregulation is linked to cancer, but the genomic status of mitoribosomal proteins (MRPs) in nonsmall cell lung cancer (NSCLC) is unclear.
Purpose of the Study:
- To investigate the genomic landscape and functional role of MRPs in NSCLC.
- To identify potential prognostic markers and therapeutic targets in NSCLC.
Main Methods:
- Comprehensive analysis of MRP expression, copy number variations, and mutations in TCGA-NSCLC patient data.
- Functional assays including gene inhibition, cell proliferation, migration, and mitochondrial function assessments.
- Transcriptomic analysis and signaling pathway investigation (ROS-p38-p21-Rb-E2F axis).
Main Results:
- MRPL47 was identified as significantly amplified and overexpressed in NSCLC.
- MRPL47 overexpression correlated with poor patient survival across independent datasets.
- MRPL47 inhibition reduced NSCLC cell proliferation and migration, impaired oxidative phosphorylation, and induced cell cycle arrest via the ROS-p38-p21-Rb-E2F pathway.
Conclusions:
- MRPL47 is a key driver in NSCLC, acting as a prognostic marker.
- MRPL47 promotes tumor progression by disrupting mitochondrial function and altering cell cycle regulation.
- Targeting MRPL47 may offer a novel therapeutic strategy for NSCLC.
More Related Videos
09:20Author Spotlight: Exploring Mitochondrial Function and Chemical Toxicity Using Drosophila melanogaster
Published on: November 10, 2023
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
